Summary & Overview
HCPCS Level II C1781: Mesh (implantable)
HCPCS Level II code C1781 denotes an implantable surgical mesh device used to provide support or reinforcement to soft tissues. This category of device is commonly employed in hernia repairs, pelvic organ prolapse procedures, and other soft-tissue reinforcement surgeries. As an HCPCS Level II supply code, C1781 is used on claims to identify the implanted mesh separately from the surgical procedure itself, which has implications for billing, coverage determinations, and device tracking.
Key payers in a national analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of how C1781 is billed across typical surgical settings, national coverage considerations, and common claim elements. The publication summarizes benchmarks for utilization and reimbursement where available, outlines relevant policy and coverage themes affecting mesh implants, and provides clinical context about typical indications and sites of service.
This resource is intended to help revenue cycle, coding, and clinical teams understand the purpose of C1781, the payer landscape, and the types of information often required on claims. Data not available in the input will be noted as such in detailed sections.
Billing Code Overview
HCPCS Level II code C1781 represents Mesh (implantable) devices used in surgical procedures. The service involves implantation of a prosthetic mesh material to provide support or reinforcement to soft tissues.
-
Service type: Implantable medical device
-
Typical site of service: Operating room or ambulatory surgical center for surgical implantation procedures
Clinical & Coding Specifications
Clinical Context
A 58-year-old female with symptomatic pelvic organ prolapse (anterior cystocele) and recurrent stress urinary incontinence presents for surgical repair. After conservative therapies (pelvic floor physical therapy, pessary) failed, the surgeon plans a transvaginal mesh-augmented anterior repair using an implantable synthetic mesh (C1781) to reinforce the weakened fascia. Preoperative workup includes history and physical, urinalysis, pelvic exam with POP-Q staging, and informed consent documenting risks of mesh placement and possible need for concomitant procedures.
Intraoperative workflow: the patient undergoes general or regional anesthesia in an ambulatory surgery center or hospital operating room. The surgeon performs cystoscopy as indicated, dissects the anterior vaginal wall, places and secures the implantable mesh to support the bladder and anterior vaginal wall, and closes the vaginal epithelium. Hemostasis and mesh tension are verified. If indicated, a mid-urethral sling or posterior repair may be performed during the same session. Postoperative monitoring includes voiding trial, pain control, wound checks, and discharge instructions with activity restrictions and follow-up planning for removal of sutures and assessment of mesh incorporation and complications.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
50 | Bilateral procedure |